
Novel Drug Therapies Could Tackle Treatment-Resistant Depression
An anesthetic, a steroid and a psychedelic are new treatments for a devastating psychiatric disorder
Husseini Manji is a physician and global head of Science for Minds at Johnson & Johnson. Science for Minds is a new initiative bringing together the three pillars of science, innovation and society to catalyze the development of novel therapeutics for neuropsychiatric and neurodegenerative disease worldwide. He was previously the chief of the laboratory of pathophysiology and the director of the mood anxiety disorders program at the National Institutes of Health.

Novel Drug Therapies Could Tackle Treatment-Resistant Depression
An anesthetic, a steroid and a psychedelic are new treatments for a devastating psychiatric disorder